IL4Ra blockade reduces Oral Immunotherapy outcome-related adverse events through inhibition of mast cell activity in a murine model of oral immunotherapy
Year: 2026
Type: article
Language: English
Subfield: Immunology and Allergy
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7128529040
FWCI:
Cites:
Cited by:
Related to:
